Pharma Manufacturing: BeOne Medicines (formerly BeiGene) will invest an additional $300M to expand its Princeton West Innovation Campus in Hopewell, pushing total U.S. spend above $1B and adding new small-molecule capacity plus about 120 jobs, with the new building targeted to be fully operational in 2029. HIV Access: Merck outlined early access plans for alimatravir, a once-monthly oral HIV PrEP pill, including early generic licensing across 129 low- and middle-income countries and regional manufacturing support. Healthcare Innovation: Johnson & Johnson won FDA De Novo authorization for its OTTAVA robotic surgical system, clearing it for multiple soft-tissue general surgery procedures and starting a limited U.S. rollout. Retail Pricing Rules: New Jersey’s Fair Price Protection Act takes aim at “surveillance pricing,” banning retailers from using personal data to set individualized grocery prices and pausing new electronic shelf-label rollouts for 12 months. Election Fallout: NJ’s noncitizen voter-roll error remains under scrutiny as the state hires an independent firm to investigate how 6,600 noncitizens were registered and about 400 voted. Local Business Openings: Jersey City welcomed new food and drink spots, including a tearoom/bakery and multiple restaurants, reflecting continued demand for neighborhood dining. Cannabis Layoffs: The Cannabist Company will close two Vineland grow sites, laying off 86 workers as it moves through Chapter 15 bankruptcy. Gaming/Hotels: White Hat Gaming will power Vegas Club Casino in NJ, while Crescent Hotels & Resorts takes over Hilton Short Hills management.